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Expression of TGF-–induced matrix protein ig-h3 is up-
regulated in the diabetic rat kidney and human proximal tubu-
lar epithelial cells treated with high glucose.
Backgrounds. ig-h3 is an extracellular matrix protein whose
expression in several cell types is greatly increased by trans-
forming growth factor- (TGF-). TGF- is believed to be
involved in the development of diabetic nephropathy and thus
we have assessed the possibility that ig-h3 may be a down-
stream molecule in this pathogenic process.
Methods. Immunoblotting and immunohistochemistry were
done using an antibody against mouse ig-h3 protein. ig-h3
and TGF- concentrations were measured by enzyme-linked
immunosorbent assay (ELISA). Cell adhesion and migration
were assessed by measuring activity of N-acetyl--d-glucosami-
nidase and using a transwell plate, respectively.
Results. Immunohistochemistry revealed that ig-h3 occurs
mainly in the basement membrane of proximal tubules, particu-
larly the S3 segment but also to lesser extents in the basement
membranes of the cortical thick ascending limb cells and the
parietal glomerular epithelial cells in Bowman’s capsule. Im-
munoblotting revealed that 68 kD bands were seen only in
the cortex  the outer stripe of the outer medulla. Rats with
streptozotocin (STZ)-induced diabetes exhibited a marked and
sustained increase in renal ig-h3 abundance. This was mir-
rored by urinary ig-h3 levels. In vitro experiments with human
primary renal proximal tubular epithelial cells revealed that
their expression of ig-h3 was greatly increased by either TGF-
or glucose. High glucose levels also stimulated TGF- produc-
tion by renal proximal tubular epithelial cells and the high glu-
cose–induced ig-h3 expression was almost completely blocked
by anti-TGF- antibody. ig-h3 mediated renal proximal tubu-
lar epithelial cells adhesion and migration.
Conclusion. ig-h3 may be important in the development of
Key words: diabetes mellitus, integrin, proximal tubule, renal failure,
tubulointerstitial fibrosis.
Received for publication July 30, 2002
and in revised form February 7, 2003
Accepted for publication April 23, 2003
 2003 by the International Society of Nephrology
1012
diabetic nephropathy. Furthermore, the level of urinary ig-h3
may be useful as an early marker reflecting disease onset and
progression.
Diabetes mellitus is associated with a characteristic
set of structural and functional kidney abnormalities re-
ferred to as diabetic nephropathy, and chronic renal fail-
ure is a common and serious complication. Consequently,
it is of considerable interest to identify the factors re-
sponsible for these abnormalities and that facilitate the
progression of renal complications. Of these, the cyto-
kine transforming growth factor- (TGF-) has emerged
as a key factor in the development of renal hypertrophy
and the accumulation of extracellular matrix in diabetic
kidneys [1, 2]. In diabetic humans and animals, TGF-
mRNA and protein levels in the glomeruli and tubulo-
interstitium are significantly increased [3, 4]. Moreover,
the administration of TGF- neutralizing antibodies to
diabetic rats prevents the structural and functional kid-
ney abnormalities from developing [5, 6]. In addition,
altered urinary TGF- levels have been suggested to be
an early predictor for assessing the progression of diabetic
nephropathy [7]. Thus, TGF- and its upstream and
downstream regulatory pathways could be potential tar-
gets for blocking and monitoring the progression of dia-
betic nephropathy.
It is possible that the extracellular matrix protein ig-
h3 may also be involved in diabetic nephropathy as ig-
h3 expression in several cell types is highly induced by
TGF- [8]. This protein has four characteristic internal
repeat domains called fas-1 domains because they share
homology with fasciclin 1, a Drosophilla neuroadhesion
molecule [9]. We have identified a motif in each of the
second and the fourth repeat domains that interacts with
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31 integrin and thereby mediates corneal epithelial cell
adhesion [10]. We also reported that ig-h3 forms a
fibrillar structure and interacts with several other extra-
cellular matrix proteins, including fibronectin and type I
collagen [11]. ig-h3 is also known to affect cell growth
[8] and differentiation [12, 13]. In the rat kidney, an in
situ hybridization study has revealed that ig-h3 mRNA
is expressed in proximal tubular epithelial cells (particu-
larly in the S3 segment) and in the juxtaglomerular appa-
ratus, and that these mRNA levels in the kidney are up-
regulated in diabetes mellitus induced by streptozotocin
(STZ) [14]. More recently, it has been suggested that ig-
h3 expression is associated with cyclosporine-induced
nephropathy in humans who had received nonrenal
transplants [15]. However, to date, the immunolocaliza-
tion of the ig-h3 protein has not been demonstrated in
the kidney and it is unclear whether ig-h3 actually does
play a pathogenic role in the kidney diseases apparently
driven by TGF- (e.g., glomerulosclerosis and tubulo-
interstitial fibrosis). To address these issues further, in
the present study we examined the immunolocalization
of ig-h3 protein in the kidneys of normal rats. We found
it was predominantly expressed in the proximal tubules
and that renal levels of ig-h3 protein were markedly
enhanced in diabetic rats. In vitro studies revealed that
primary human renal proximal tubular epithelial cells
increase their ig-h3 expression when exposed to high
glucose or TGF- treatment, and thatig-h3 can mediate
the adhesion and migration of renal proximal tubular
epithelial cells. We developed an enzyme-linked immu-
nosorbent assay (ELISA) to measure urinary ig-h3 con-
centrations and found that they mirrored renal ig-h3
protein levels, indicating urinary ig-h3 could be useful
as an early predictor for the development of diabetic
nephropathy and for monitoring the progression of the
disease.
METHODS
Experimental animals and protocols
Adult male Sprague-Dawley rats weighing 240 to 260 g
maintained on a standard rodent diet with free access
to water were randomly divided into control and experi-
mental groups. Diabetes mellitus was induced by an in-
traperitoneal injection of STZ (60 mg/kg body weight)
(Sigma Chemical Co., St. Louis, MO, USA) in 0.1 mol/L
citrate buffer, pH 4.5. Control rats received the citrate
buffer alone. Blood glucose levels were determined 2 days
after STZ injection and rats with blood glucose higher
than 250 mg/dL were considered to be diabetic. Five
groups of rats were examined. Three groups consisted
of diabetic rats sacrificed 5, 10, and 15 days after STZ
treatment (N  7, 8, and 8, respectively). A group of
five control rats was sacrificed 15 days after receiving
citrate buffer. In a separate experiment, spot urine sam-
ples from six rats injected with STZ were collected for
25 days. For the first four groups, rats were housed 24
hours prior to sacrifice in metabolic cages for the mea-
surement of water intake and urine output. The concen-
tration of ig-h3 in the urine was determined by indirect
competitive ELISA (Regen Biotech, Seoul, Korea). Cre-
atinine levels in plasma and urine were measured by the
Creatinine Set (Asan Pharma., Seoul, Korea). Immedi-
ately prior to sacrifice, rats were weighed and anesthe-
tized by intraperitoneal injection of pentobarbital so-
dium (1 mL/kg body weight). Blood was collected for the
determination of plasma glucose and plasma creatinine.
The right kidneys were rapidly removed and processed
for Western blot analysis (see below) while the left kid-
neys were examined by immunohistochemistry (see be-
low). With regard to the group of rats monitored for 25
days, serial spot urine samples were taken and assessed
for the presence of ig-h3. Urinary ig-h3 levels were
corrected by the creatinine concentration in the urine.
These rats were then sacrificed and their kidneys exam-
ined by immunohistochemistry.
Antibodies against ig-h3
The antihuman ig-h3 antibody used has been charac-
terized previously [16]. To make an antimouse ig-h3
antibody, we first made recombinant mouse ig-h3 pro-
tein. A DNA fragment encoding amino acids 24 to 618
of mouse ig-h3 was inserted into the BamH1/Xho1 sites
of pET-29b vector (Novagen, Madison, WI, USA) and
expressed in Escherichia coli. The his-tagged recombi-
nant mouse ig-h3 protein was purified using Ni-NTA
resin (Qiagen, Valencia, CA, USA) according to the
manufacturer’s instructions. Rabbits received a subcuta-
neous injection of the protein (200 g) in Complete
Freund’s Adjuvant followed by four immunizations spaced
by 3 weeks with 200 g protein in Incomplete Freund’s
Adjuvant. Antibody titers were monitored by immu-
noblot analysis using the recombinant ig-h3 protein.
The antiserum was further purified by Protein A affinity
chromatography (Amersham Biosciences, Uppsala, Swe-
den) according to the manufacturer’s protocol. The spec-
ificity of the antimouse ig-h3 antibody was tested by
Western blotting the supernatants of several mouse cell
lines (NIH3T3 fibroblasts, KS483 osteoblasts, and podo-
cytes) treated with TGF-, which revealed that only the
expected bands were detected (data not shown). Western
blotting rat kidney extracts or supernatants of several
TGF-–treated rat cell lines [rat vascular smooth muscle
cells, buffalo rat liver cells (BRL) and normal rat kidney
(NRK) cells] revealed that the antimouse ig-h3 anti-
body crossreacts to rat ig-h3 (data not shown).
Electrophoresis and Western blotting
The right kidneys were divided into three parts (cortex
the outer stripe of outer medulla, inner stripe of outer
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medulla, and inner medulla) and homogenized with a
solution of 0.3 mol/L sucrose, 25 mmol/L imidazole, 1
mmol/L ethylenediaminetetraacetic acid (EDTA), pH
7.2, containing 8.5 mmol/L leupeptin, and 100 g/mL
pefabloc, using an ultraturrax T8 homogenizer (IKA La-
bortechnik, Staufen, Germany) at maximum speed for
15 seconds. Each sample was then centrifuged at 4000g
for 15 minutes at 4C to remove whole cells, nuclei, and
mitochondria. The protein concentration in the superna-
tant was measured by the Bradford method using the
Bio-Rad Protein Assay Kit (Bio-Rad, Hercules, CA,
USA) according to the manufacturer’s protocol. Protein
(100 g) from each sample was solubilized at 100C for
5 minutes in Laemmli sample buffer and run on 10%
polyacrylamide minigels (Bio-Rad Mini Protean II). The
gels were then subjected to Western blotting. After trans-
fer by electroelution to nitrocellulose membranes, blots
were blocked overnight at 4C with 3% skim milk in
Tris-buffered saline with 20% Tween (TBST), pH 7.4,
and then incubated with primary antibodies for 2 hours
at room temperature. An antibody for -tubulin was
purchased from Santa Cruz Biotechnology, Inc. (Santa
Cruz, CA, USA). The labeling was visualized with horse-
radish peroxidase (HRP)–conjugated secondary anti-
body (P448 diluted 1:3000; Dako, Glostrup, Denmark)
using an enhanced chemiluminescence system (Amer-
sham Pharmacia Bio-tech).
Immunohistochemistry
Kidneys from normal (N  5) and diabetic rats (N 
5, 25 days after STZ injection) were fixed by retrograde
perfusion via the aorta with 4% paraformaldehyde in 0.1
mol/L cacodylate buffer, pH 7.4. For immunoperoxidase
microscopy, kidney blocks containing all kidney zones
were dehydrated and embedded in paraffin. For light
microscopy, the paraffin-embedded tissues were cut into
3m sections using a rotary microtome. For immunoper-
oxidase labeling, endogenous peroxidase was blocked by
0.5% H2O2 in absolute methanol for 10 minutes at room
temperature. To reveal antigens, sections were put in a
1 mmol/l Tris solution, pH 9.0, supplemented with 0.5
mmol/L ethyleneglycol tetraacetate (EGTA) and heated
in a microwave oven for 10 minutes. Nonspecific immu-
noglobulin binding was prevented by incubating the sec-
tions in 50 mmol/L NH4Cl for 30 minutes followed by
blocking with phosphate-buffered saline (PBS) supple-
mented with 1% bovine serum albumin (BSA), 0.05%
saponin, and 0.2% gelatine. Sections were incubated
overnight at 4C with antimouse ig-h3 antibody or anti-
NaH exchange (NHE3) antibody [17] diluted in PBS
supplemented with 0.1% BSA and 0.3% Triton-X 100
(1:2000). Labeling was visualized with the HRP-conju-
gated secondary antibody (P448, 1:200, Dako). Immuno-
labeling controls were performed by using antibodies
preabsorbed with immunizing peptides. Microscopy was
performed using a Zeiss light microscope (Axioplan2
imaging; Carl Zeiss, Inc., Jena, Germany).
ELISA measuring ig-h3 levels
Plastic flat microtiter 96-well plates (Corning, NY)
were coated overnight at 4C with 0.5 g/mL wild-type
ig-h3 protein in 20 mmol/L carbonate-bicarbonate
buffer, pH 9.6, with 0.02% sodium azide. The plates were
rinsed three times in PBS-0.05% Tween 20 (PBST) and
kept at 4C. Lyophilized culture media or rat urine were
preincubated with anti-ig-h3 antibodies (diluted 1:2000
in PBST) in 96-well plastic round microtiter plates for
90 minutes at 37C, transferred to the precoated plate,
and incubated for 30 minutes at room temperature. The
plates were rinsed three times in PBST and incubated
for 90 minutes at room temperature with peroxidase-
conjugated antirabbit IgG antibodies (diluted 1:2000 in
PBST, Amersham Pharmacia Biotech). The plates were
rinsed three times in PBST and incubated for 60 minutes
at room temperature in the dark with 200 L of the
substrate solution (100 g/mL o-phenylenediamine and
0.003% H2O2). After stopping the reaction with 50 L/
well 8 N H2SO4, the absorbance was read at 490 nm using
a Bio-Rad Model 550 microplate reader.
Renal proximal tubule epithelial cells
The human primary renal proximal tubule epithelial
cells are commercially available from Clonetics (San
Diego, CA, USA) and were maintained in renal epithe-
lial cell growth medium (REGM) (Clonetics). Only the
cells of the first and second passages were used in experi-
ments. Confluent quiescent cells were incubated with the
indicated TGF- concentrations for 48 hours.ig-h3 pro-
tein levels in the cell supernatants were estimated by
Western blotting and ELISA. The cells were also exposed
for 3 and 5 days to 130 to 630 mg/dL glucose and ig-h3
protein and active TGF-1 levels in the supernatants were
measured by separate ELISAs (see above and R&D Sys-
tems, Minneapolis, MN, USA, respectively). The total
protein content of the culture supernatants was also mea-
sured and TGF-1 levels were expressed as picograms/
milligrams of protein. Renal proximal tubule epithelial
cells were also incubated for 3 or 5 days with normal
glucose or with high glucose media plus 30 g/mL anti-
TGF-1 antibody or 30 g/mL nonspecific immunoglob-
ulin G (IgG). The results shown are derived from three
separate experiments, with duplicates performed in each
experiment.
Cell adhesion assay
The cell adhesion assay was performed as described
previously [10]. Briefly, 96-well microculture plates (Fal-
con, Becton-Dickinson, Mountain View, CA, USA) were
coated at 4C overnight with proteins (10g/mL) diluted
in PBS. The plates were then rinsed three times in PBS
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and uncoated surfaces were blocked for 1 hour at 37C
with PBS containing 2% heat-inactivated BSA. The
plates were rinsed again and 2  104 renal proximal
tubule epithelial cells were added to each well in 100 L
culture medium. After incubation for 1 hour at 37C,
unattached cells were removed by rinsing twice with PBS.
Attached cells were incubated for 1 hour at 37C in 50
mmol/L citrate buffer, pH 5.0, containing 3.75 mmol/L
p-nitrophenyl-N-acetyl--d-glucosaminide (hexosamini-
dase substrate) and 0.25% Triton X-100. The reaction
was stopped and color developed by the addition of 50
mmol/L glycine buffer, pH 10.4, containing 5 mmol/L
EDTA. The absorbance was measured at 405 nm in Bio-
Rad Model 550 microplate reader. Triplicates were used
in each experiment. Data are shown as the mean area
at specific time points  SD.
Migration assay
The cell migration assay was performed using trans-
well plates (8 m pore size) (Costar, Cambridge, MA,
USA). The undersurface of the membrane was coated
at 4C overnight with 10 g/mL BSA, fibronectin, or
ig-h3 protein diluted in PBS and then blocked with 2%
BSA. The upper compartment was seeded with 3  105
renal proximal tubule epithelial cells per well in 200 L
medium. After 6 hours of migration, cells in the upper
chamber of the filter were removed and nonmigrating
cells on the top of the filters were removed with a cotton
swab. Renal proximal tubule epithelial cells on the lower
side of the filter were fixed with 8% glutaraldehyde
(Sigma Chemical Co.) and stained with 0.25% Crystal
Violet (Sigma Chemical Co.) in 20% methanol (wt/vol).
Each experiment used duplicate wells and, within each
well, counting was done in nine-randomly selected mi-
croscopic high power fields (200).
Statistical analysis
The difference between two mean values was analyzed
by the Student t test and was considered to be statistically
significant when P 	 0.05 or P 	 0.01.
RESULTS
Immunolocalization of ig-h3 in the control rat kidney
Immunoperoxidase microscopy revealed that ig-h3
labeling in control rat kidney was exclusively present at
the inner cortex and the outer stripe of the outer medulla
(Fig. 1A). With higher magnification view of these zones,
the most prominent labeling was observed at the proxi-
mal tubule cells (Fig. 2A, arrows) in the medullary rays
(Fig. 1A) where S3 straight proximal tubule segments
are mainly present. In the S3 straight proximal tubule,
immunolabeling of the ig-h3 was associated with the
basement membranes (Fig. 2 A and C, arrows), whereas
no labeling was seen in the apical and basolateral plasma
membranes or intracelluar structures (Fig. 2 A and C).
In contrast, no or very weak labeling was seen in the S1
and S2 segment of the proximal tubules (Fig. 2 E and
F). The selective immunolocalization in the S3 segment
of the proximal tubule was further demonstrated by a
control study of type 3 Na-H exchanger (NHE3) labeling
in rat kidney (Fig. 1B). In contrast to the ig-h3 labeling
in the medullary rays (mainly S3 segment), NHE3 was
strongly present at the apical domains of S1 and S2 con-
voluted proximal tubules with much weaker staining of
the S3 straight proximal tubule in the medullary ray (Fig.
1B), as previously described [18]. Thus, this indicates the
selective immunolocalization of ig-h3 in the S3 segment
of the proximal tubule. In the inner cortex and the outer
stripe of the outer medulla, weak labeling was also associ-
ated with the basement membranes of the connecting
tubules and collecting ducts (Fig. 2B). However, the la-
beling in the collecting duct was not seen in the inner
stripe of outer medulla and inner medulla. In the inner
stripe of the outer medulla, no labeling was observed at
the thick ascending limb (Fig. 2D), thin limb structure
(Fig. 2D) and collecting duct (Fig. 2D). In glomeruli, the
ig-h3 labeling was weakly observed at the basal part of
the parietal epithelial cells in the Bowman’s capsule (Fig.
2E and Fig. 2F, arrows), whereas podocytes, mesangial
cells, or endothelial cells were unlabeled. Labeling is
also seen at the basement membrane of the cortical thick
ascending limb (Fig. 2F, arrowhead). Immunolabeling
controls using antibodies preabsorbed with immunizing
peptides were negative (Fig. 1C).
Western blotting was performed using extracts from
three different kidney zones from normal rat kidneys,
namely, cortex outer stripe of the outer medulla, inner
stripe of the outer medulla, and inner medulla. A single
band with the predicted molecular mass of ig-h3 (68 kD)
was detected only in cortex  outer stripe of the outer
medulla extracts (Fig. 1D). This is consistent with the
immunoperoxidase microscopy experiments that revealed
that ig-h3 protein occurs in the basement membranes
of the proximal tubular epithelial cells (mainly S3 seg-
ments), cortical thick ascending limb cells, and parietal
epithelial cells of Bowman’s capsule.
ig-h3 protein levels in kidneys and urine are
markedly increased in diabetic rats
As expected, compared to control rats, rats with STZ-
induced diabetes mellitus had high blood glucose levels
and altered renal functions. For example, rats examined
5, 10, or 15 days after STZ injection had a significantly
elevated urine output, water intake, and glomerular fil-
tration rate (GFR) as measured by creatinine clearance
(Table 1). This is consistent with previous observations
on the early phase of diabetes mellitus [19–21]. The abun-
dance of ig-h3 protein in the kidneys was measured by
Western blotting analysis and quantitated by Scion Im-
age (Scion Corporation, Frederick, MD, USA). The
abundance of -tubulin was also measured as a internal
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Fig. 1. Immunohistochemical analyses ofig-h3
and NHE3 using immunoperoxidase labeling
of sections from paraffin-embedded kidney tis-
sue from control Sprague-Dawley rats. (A )
The ig-h3 immunolabeling is predominantly
associated with tubular structures located
mainly in the medullary rays (MR) and outer
stripe of the outer medulla (OSOM) (magnifi-
cation 150). (B ) NHE3 labeling is strongly
present at the apical domains of S1 and S2
convoluted proximal tubules in the outer cor-
tex (Cor) with much weaker staining of the S3
straight proximal tubules in the medullary rays
(MR). The labeling of the thick ascending limb
is also seen in both the cortex and outer me-
dulla (magnification150). (C ) Immunostain-
ing controls using antibodies preabsorbed with
immunizing peptides is negative. (D ) Protein
extracts were run on a gel and blotted with
antimouse-ig-h3 antibody. A single band at
approximately 68 kD was observed in the
OSOM  Cortex extracts but not in the other
extracts. Abbreviations are: Inner M, inner
medulla; ISOM, inner stripe of the outer me-
dulla.
Fig. 2. Immunoperoxidase labeling of ig-h3
in sections from paraffin-embedded kidney tis-
sue from control Sprague-Dawley rats. (A ) In
the S3 segment of the proximal tubules (P),
immunolabeling of theig-h3 is exclusively asso-
ciated with the basement membranes (arrows),
whereas no labeling is seen in the apical and
basolateral plasma membranes or intracelluar
structures (magnification 630). (B ) Labeling
is also seen at the cortical collecting ducts (C)
(magnification 630). (C ) Higher magnifica-
tion view of S3 segment of the proximal tubule
(P). Labeling is exclusively associated with
basement membranes (arrows) (magnification
1000). (D ) In the inner stripe of the outer
medulla, no labeling is seen at the thick as-
cending limb (T), thin limb structure (*) and
collecting duct (C) (magnification 630). (E )
In glomeruli (Glo), the ig-h3 labeling is
weakly observed at the basal part of the pari-
etal epithelial cells in the Bowman’s capsule
(arrows), whereas no labeling is seen at podo-
cytes, mesangial cells or endothelial cells (mag-
nification 630). (F ) Labeling is also seen at
the basal part of the parietal epithelial cells
in the Bowman’s capsule (arrow), as well as
cortical thick ascending limb (arrowhead) (mag-
nification 630).
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Table 1. Laboratory data in nondiabetic and diabetic rat
Control Diabetes mellitus Diabetes mellitus Diabetes mellitus
(N  5) day 5a (N  7) day 10a (N  8) day 15a (N  8)
Total number 28 23 16 8
Body weight g 267.621.7 256.626.5 269.215.7 265.432.5
Water uptake mL/day 32.66.4 122.180.7b 231.163.8b 218.627.5b
Urine output mL/day 13.74.5 90.959.8b 156.441.5b 167.228.2b
Blood glucose mg/dL 161.616.7 292.755.0b 439.684.2b 568.348.8b
24-hour creatinine clearance mg/min 1.30.4 2.30.5b 2.51.5 2.40.5b
Urinary protein mg/mL 2.00.8 2.11.0 1.90.7 2.01.1
24-hour urinary ig-h3/creatinine ng/mg 48.216.4 144.086.0b 182.748.1b 164.355.4b
Results are given as mean standard deviation.
aDays after streetozotocin injection
bSignificantly different from control, P 	 0.05
Fig. 3. Western blotting analysis ofig-h3 in extracts from the cortex
the outer stripe of outer medulla in control and diabetic rat kidneys.
(A) ig-h3 abundance in the cortex  outer stripe of the outer medulla
is uniformly increased in the kidneys of rats with early-phase diabetes
mellitus (DM) (days 5 to 15 after streptozotocin treatment). This was
detected by the antimouse-ig-h3 antibody. -tubulin abundance is also
shown as an internal control. (B) The abundance of ig-h3 and -tubu-
lin was quantitated using Scion Image and the ratios of ig-h3/-tubulin
are expressed. *Significantly different from control, P 	 0.01.
control and used for the correction of loading amounts.
Diabetic rat kidneys contained higher ig-h3 levels com-
pared with those from control rats (Fig. 3). This increase
was already obvious 5 days after the STZ injection and
these levels were maintained up to 15 days after injection.
These observations fit with the immunohistochemical
studies on the diabetic kidneys (data not shown), which
showed again that ig-h3 immunolabeling was largely
associated with the proximal tubules and that the label-
ing of the S1 and S2 segments of the proximal tubules
was more prominent than in control kidneys.
We also used an ELISA to measure ig-h3 in urine
samples collected 24 hours before sacrifice at days 5, 10,
Fig. 4. Urinary ig-h3 concentrations in spot urine samples of diabetic
rats. Urinary ig-h3 concentrations were measured at every 5 days after
streptozotocin injection. The concentration of ig-h3 (ng/mg creatinine)
increased progressively during the whole experimental period in each
diabetic rat.
and 15 (Table 1). Sequential spot urine samples from a
separate set of rats obtained 0, 5, 10, 15, 20, and 25 days
after STZ injection were also measured (Fig. 4). Urinary
ig-h3 excretion levels of all diabetic rats were signifi-
cantly higher at day 5 and increased gradually thereafter,
which is consistent with the increased abundance of ig-
h3 in diabetic kidneys. This suggests that urinary ig-h3
levels, as measured by ELISA, could reflect kidney ig-
h3 levels in parallel with altered renal functions and thus
could be used as an early marker for the development
of diabetic nephropathy.
High glucose induces renal proximal tubule epithelial
cells to express more ig-h3 by increasing
their TGF- expression
Primary human renal proximal tubular epithelial cells
were cultured and their supernatants were examined by
Western blot and ELISA for the presence of ig-h3.
This revealed that renal proximal tubule epithelial cells
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Fig. 5. Transforming growth factor-1 (TGF-1) induces renal proxi-
mal tubular epithelial cells to express ig-h3. Confluent quiescent cells
were incubated with the indicated TGF-1 concentrations for 48 hours.
ig-h3 protein levels in the cell supernatants were estimated by western
blotting (A) and enzyme-linked immunosorbent assay (ELISA). (B).
The values quoted are the mean  standard deviation of triplicates.
*Significantly different from control, P 	 0.05.
constitutively express the 68 kD protein (Fig. 5). When
we added exogenous TGF- to the renal proximal tubule
epithelial cell cultures, we found that ig-h3 production
was markedly increased in a dose-dependent manner
(Fig. 5 A and B). We then assessed whether high glucose
could have a similar effect. Figure 6A demonstrates that
glucose also stimulates renal proximal tubule epithelial
cells to increase ig-h3 production in a time- and dose-
dependent fashion. This up-regulation is specific for d-glu-
cose because d-mannitol failed to stimulate ig-h3 pro-
duction (Fig. 6A). To test whether high glucose levels
also increase renal proximal tubule epithelial cell synthe-
sis of TGF-, total TGF- protein in the supernatant
was measured by ELISA. Renal proximal tubule epithe-
lial cells exposed for 3 or 5 days to high ambient glucose
concentrations secreted more TGF- protein into the
culture media in a time- and dose-dependent manner
(Fig. 6B). As high glucose levels stimulate renal proximal
tubule epithelial cell production of both ig-h3 and
TGF-, we hypothesized that the glucose-stimulated
production of ig-h3 might be mediated by TGF-. Sup-
porting this is that the anti-TGF- antibody almost com-
pletely blocked the production of ig-h3 stimulated by
high glucose levels (Fig. 6C). Thus, high glucose levels
stimulate renal proximal tubule epithelial cells to pro-
duce TGF-, which in turn induces ig-h3 expression.
ig-h3 mediates renal proximal tubule epithelial cell
adhesion and migration
We demonstrated previously that ig-h3 can serve as
a substrate for cell adhesion [10]. In addition, our immu-
nohistochemical study here showed thatig-h3 is present
in the basement membrane of the S3 segments of proxi-
mal tubular epithelial cells. This suggests that ig-h3
might mediate the adhesion and migration of renal proxi-
mal tubule epithelial cells. We examined the ability of
renal proximal tubule epithelial cells to bind to BSA,
fibronectin, or ig-h3 and found that ig-h3 mediates
the binding of these cells as well as fibronectin (Fig. 7A).
Furthermore, we assessed the ability of ig-h3 to support
renal proximal tubule epithelial cell migration and found
it was comparable to fibronectin (Fig. 7B).
DISCUSSION
The present study demonstrates that ig-h3 protein is
predominantly expressed in close association with the
basement membrane of the proximal tubule S3 segment
in both normal and diabetic rat kidneys. Western blot
analysis also showed that ig-h3 is detected only in the
kidney cortex and the outer stripe of the outer medulla
but not in the inner stripe of the outer medulla or the
inner medulla. These observations are consistent with a
previous report showing that ig-h3 mRNA is mainly
localized to the pars recta (S3 segment) of the proximal
tubules of the rat kidney [14]. The fact thatig-h3 expres-
sion is closely associated with the basement membrane
suggests that ig-h3 may mediate tubular epithelial cell
adhesion and migration in both physiologic and patho-
logic conditions. This was supported by our observation
that ig-h3 mediates the adhesion and migration of cul-
tured renal proximal tubule epithelial cells. We also found
that ig-h3 mediates renal proximal tubule epithelial cell
adhesion and migration by interacting with 31 integrin
using motifs within the second and the fourth repeat
domains of ig-h3 (data not shown). This is similar to our
previously published observations on ig-h3-mediated
corneal epithelial cell adhesion [10].
In human diabetes mellitus patients and experimental
animal diabetes mellitus models, TGF-mRNA and pro-
tein levels are significantly increased in the kidney glo-
meruli and tubulointerstitium [3, 22]. A recent study has
indicated that the kidney proximal tubule may be an
important site of TGF- and extracellular matrix protein
expression in experimental diabetes [23]. This is sup-
ported by an additional observation that the high glu-
cose-stimulated increase of collagen and fibronectin pro-
duction in mesangial cells and proximal tubular cell is
mediated by TGF- activation [24–26]. These facts led
us to examine the effect of exogenous TGF- or high
glucose levels on ig-h3 expression by renal proximal
tubule epithelial cells. Significantly, we found that ig-h3
production in vitro is greatly increased by either TGF-
or glucose in a dose-dependent manner. Furthermore,
we found that high glucose levels also stimulate renal
proximal tubule epithelial cells to increase their TGF-
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Fig. 6. High glucose levels induce renal proximal tubular epithelial
cells to secrete transforming growth factor- (TGF-), which in turn
inducesig-h3 expression. (A) High glucose levels stimulate renal proxi-
mal tubular epithelial cells to produce ig-h3 in a dose-dependent
manner. (B) High glucose levels stimulate renal proximal tubular epithe-
lial cells to produce TGF- in a dose-dependent manner. After 3 and
5 days of exposure to 130 to 630 mg/dL glucose, ig-h3 and TGF-1
protein levels were measured by enzyme-linked immunosorbent assay
(ELISA). (C) An anti-TGF-1 antibody blocked the high glucose–
induced ig-h3 expression by renal proximal tubular epithelial cells.
Cells were incubated for 5 days with normal glucose (low) or with high
glucose (high) media plus 30 g/mL anti-TGF-1 antibody (TGF-
Ab) or 30 g/mL nonspecific immunoglobulin G (IgG). The results
shown were derived from 3 separate experiments, with duplicates per-
formed in each experiment. *Significantly different from control, P 	
0.05.
Fig. 7. ig-h3 enhances renal proximal tubular epithelial cells adhesion and migration. (A) Adhesion of renal proximal tubular epithelial cells to
surfaces coated with bovine serum albumin (BSA), plasma fibronectin (pFN), or ig-h3. The cells were rinsed with phosphate-buffered saline
(PBS), fixed, and stained with crystal violet. (B) Support of renal proximal tubular epithelial cell migration by BSA, pFN, and ig-h3 was assayed
using a 6-well transwell assay as described in the Methods section. Cells that migrated through the filter to the lower side were fixed and stained.
All data are presented as mean  SD of triplicate determinations from three experiments. *Significantly different from control, P 	 0.05
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production, and that addition of an anti-TGF- antibody
to high glucose–stimulated renal proximal tubule epithe-
lial cells almost completely blocks ig-h3 expression.
These results strongly indicate that high glucose levels
increase ig-h3 production by renal proximal tubule epi-
thelial cells by activating TGF-.
Our in vivo experiments also showed that ig-h3 ex-
pression is significantly increased in diabetic kidneys.
Our observations support the notion that in diabetes,
high glucose levels lead to the production of TGF-
by the proximal tubule [23], which then induces local
expression of ig-h3. How could such increased ig-h3
expression have pathologic consequences? As it is now
evident that a progressive decline in renal function in
diabetes mellitus is closely correlated with the degree of
renal interstitial fibrosis [27, 28], it is possible that ig-
h3 might be critical in promoting such renal fibrosis.
Consistent with this are our observations that ig-h3 has
a fibrillar structure and interacts with several extracellu-
lar matrix proteins, including type I collagen, fibronectin,
and laminin [11]. Furthermore, ig-h3 is known to be
associated with extracellular matrix proteins in many
different tissues [29, 30]. In addition, ig-h3 is known to
be produced by fibroblasts and to mediate fibroblast
adhesion [31]. However, it is unclear why ig-h3 expres-
sion is restricted to only the proximal tubules. The physi-
ologic significance of the restricted expression remains
to be investigated.
Early changes in incipient diabetic kidney disease are
characterized by an increase in kidney size, glomerular
volume, and enhanced GFR, and later by the develop-
ment of mesangial cell proliferation, accumulation of
glomerular extracellular matrix, increased urinary albu-
min excretion, glomerular sclerosis, and tubular fibrosis.
The subsequent overt diabetic nephropathy is clinically
characterized by proteinuria, hypertension, and progres-
sive renal insufficiency [20, 32–34]. Naturally, studies
searching for the pathogenic mechanisms responsible for
the onset of diabetic kidney disease have focused on the
early events. Recent studies have suggested that TGF-
might initiate the early diabetic renal changes and that
downstream molecules triggered by TGF-might be crit-
ically involved in the development of diabetic kidney
disease [35, 36]. For this reason, urinary TGF-1 has
been suggested to be an early marker for diabetic ne-
phropathy [7, 37, 38]. We propose here that urinary ig-
h3 levels may also be an early marker as ig-h3 is a
TGF-–induced gene product whose levels could be a
direct index of TGF- bioactivity [14]. This is supported
by our observations that ig-h3 expression is up-regu-
lated by high glucose and TGF- levels and that early in
diabetic nephropathy, renal ig-h3 abundance increases
markedly. These observations led us to test whether uri-
nary ig-h3 concentrations could be early indicators of
diabetic nephropathy. Indeed, we found that urinary ig-
h3 concentrations increased significantly as early as 5
days after the induction of diabetes. Thereafter, urinary
ig-h3 concentrations gradually increased further and
were maintained at high levels during the experimental
period (25 days). Since renal ig-h3 abundance follows
an identical pattern, the increased urinary ig-h3 levels
appear to reflect the ig-h3 levels in the kidney.
That ig-h3 is mainly localized to its site of synthesis
in the proximal tubular epithelium (particularly, in the
S3 segment) suggests that changes in urinary ig-h3 con-
centrations during diabetic onset might reflect tubular
damage rather than glomerular abnormalities. Micro-
albuminuria levels have been widely accepted as indicat-
ing an increased risk of developing diabetic nephropathy.
However, concerns have been raised that the prognostic
value of microalbuminuria levels is not accurate enough
for this marker to be used in clinical decision making or
in the design of certain clinical trials [39]. In addition,
there have been reports that tubular involvement may
precede glomerular involvement in diabetic nephropa-
thy [7, 40]. Thus, to detect the early stage of diabetic
nephropathy and to monitor the disease progression,
it is desirable to have markers that represent tubular
dysfunction as well as measuring urinary albumin excre-
tion. We propose that urinary ig-h3 concentrations may
be such an early marker for diabetic nephropathy. At
the very least, it could be useful as an index of TGF-
bioactivity in the kidney. These possibilities indicate that
it is warranted to test the clinical significance of urinary
ig-h3 concentrations in human patients.
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